In both males and females, estrogen signaling improved glucose tolerance and insulin sensitivity and may be considered the key factor between the two sexes in the sex-specific regulation of glucose homeostasis and, in turn, in many metabolic disorders such as T2D or NAFLD [120,126]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.